Tuomas Kiviniemi
MD, PhD, FESC
tuoski@utu.fi |
Cardiology; Clinical trials; Atrial fibrillation; Coronary artery disease; Percutaneous coronary intervention; Wearables; Anticoagulation; Bleeding; Translational research
Professor of cardiology, PI in CAREFIB and LAA-CLOSURE
Tuomas Kiviniemi, MD, PhD, FESC, is Professor of Cardiology at the University of Turku and Chief Physician at the Heart Center, Turku University Hospital. His clinical and academic work focuses on interventional cardiology, atrial fibrillation, and cardiovascular risk in patients undergoing cardiac procedures. He also serves as President of the Finnish Cardiac Society for the 2024–2026 term, contributing nationally to cardiovascular care development and professional education.
Professor Kiviniemi completed his medical and doctoral degrees at the University of Turku and later broadened his research expertise during a research fellowship at Brigham and Women’s Hospital, Harvard Medical School. His research integrates clinical trials, biomarker studies, translational science, and outcome research in percutaneous and surgical cardiac interventions. He leads the multidisciplinary CAREFIB Consortium, which encompasses several major investigator-initiated studies, including CAREBANK, CAREiCON and the LAA-CLOSURE randomized trial program investigating stroke prevention strategies in atrial fibrillation.
His scientific output includes peer-reviewed publications, book chapters, trial leadership roles, and long-term collaborations with computational medicine, imaging, and device-innovation groups.
In addition to his academic duties, Professor Kiviniemi is a frequently invited expert in the European Society of Cardiology community, contributing as an abstract reviewer, session chair, and presenter in acute coronary syndromes and interventional cardiology themes.
At the national level, he has served as a long-standing member and chair within the Finnish Cardiac Society, holding multiple leadership and editorial roles. As President of the Society 2024-2026, he advanced cardiovascular education, guidelines, and professional collaboration across Finland.
Professor Kiviniemi’s current research interests span atrial fibrillation detection technologies, outcomes after cardiac surgery, advanced imaging, and digital health solutions. His work continues to bridge clinical cardiology with engineering, data science, and translational discovery, supporting the University of Turku’s strategic strengths in cardiovascular medicine.
At the University of Turku, Professor Kiviniemi is actively involved in supervising doctoral trainees in cardiology, and he has mentored more than ten completed PhD theses. His teaching activities also include specialist training and contributions to national cardiology textbooks.
- Outcome after coronary artery bypass grafting and percutaneous coronary intervention in patients with stage 3B-5 chronic kidney disease (2015)
- European Heart Journal
- Predictors of permanent work disability among ≤50-year-old patients undergoing percutaneous coronary intervention. (2015)
- Scandinavian Journal of Work, Environment and Health
- Predictors of permanent work disability in patients under 50 years old undergoing percutaneous coronary intervention (2015) Gunn JM, Kiviniemi TO, Biancari F, Airaksinen J
- Renal Impairment and Prognosis of Patients with Atrial Fibrillation Undergoing Coronary Intervention - The AFCAS Trial (2015)
- PLoS ONE
- Sepelvaltimoiden fysiologian mittaaminen invasiivisesti - paine ja virtaus (2015)
- Sydänääni: Suomen Kardiologisen Seuran Lehti
- Tromboembolisten tapahtumien esto eteisvärinäpotilaalla (2015)
- BestPractice Diabetes ja sydänsairaudet
- Ventricular rate during acute atrial fibrillation and outcome of electrical cardioversion: The FinCV Study (2015)
- Annals of Medicine
- A Miniature MEMS Only Based Method of Detecting Atrial Fibrillation (2014)
- European Journal of Preventive Cardiology
- Bare-metal vs. drug-eluting stents in patients with atrial fibrillation undergoing percutaneous coronary intervention (2014)
- Circulation Journal
- Bivalirudin use during percutaneous coronary intervention in patients on chronic warfarin therapy (2014)
- Thrombosis Research
- CHADS2, CHA2DS2-VASc and HAS-BLED as predictors of outcome in patients with atrial fibrillation undergoing percutaneous coronary intervention (2014)
- Thrombosis Research
- Comparison of 30-day and 5-year outcomes of percutaneous coronary intervention versus coronary artery bypass grafting in patients aged≤50 years (the Coronary aRtery diseAse in younG adultS Study). (2014)
- American Journal of Cardiology
- Comparison of outcome after PCI and CABG in patients with chronic kidney disease Stage 3B to Stage 5 (2014) Anna Lautamäki, Tuomas Kiviniemi, Fausto Biancari, Jarmo Gunn
- Impact of anaemia on clinical outcome in patients with atrial fibrillation undergoing percutaneous coronary intervention: insights from the AFCAS registry (2014)
- BMJ Open
- One-Year Outcome of Patients With Atrial Fibrillation Undergoing Coronary Artery Stenting: An Analysis of the AFCAS Registry (2014)
- Clinical Cardiology
- Outcome after coronary artery bypass surgery and percutaneous coronary intervention in patients with atrial fibrillation and oral anticoagulation. (2014)
- Annals of Medicine
- Performance of bleeding risk-prediction scores in patients with atrial fibrillation undergoing percutaneous coronary intervention. (2014)
- American Journal of Cardiology
- Prognosis and disease progression in patients under 50 years old undergoing PCI: the CRAGS (Coronary aRtery diseAse in younG adultS) study. (2014)
- Atherosclerosis
- Transthoracic echocardiography for non-invasive assessment of coronary vasodilator function after DES implantation. (2014)
- EHJ Cardiovascular Imaging / European Heart Journal - Cardiovascular Imaging
- Usefulness of troponin T to predict short-term and long-term mortality in patients after hip fracture. (2014)
- American Journal of Cardiology



